Marek Trneny
0000-0002-6952-6073
Ústav Hematologie a Krevní Transfúze
181 papers found
Refreshing results…
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database
Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial
Mantle Cell Lymphoma - Cutting edge Dia-gnostics and Treatment Approaches | Lymfom z plášťových buněk - současný stav poznání a možnosti léčby
Malignant Lymphomas - Past, Present and Future | Maligní lymfomy minulost, současnost a budoucnost
Hodgkin´s Lymhoma - the Treatment Aproaches Development and Current Trends | Hodgkinův lymfom - vývoj léčebných přístupů a současné trendy
Current Approaches in Cancer Immunotherapy | Současné možnosti imunoterapie nádorových onemocnění
Follicular Lymphoma | Folikulární lymfom
Salvage Treatment and the Role of Transplantation in Lymphomas | Záchranná léčba a role transplantací u lymfomů
Editorial | Editorial
Diffuse Large B cell Lymphoma - Modern Dia-gnostics and Molecularly Targeted Treatment | Difuzní velkobuněčný B lymfom - moderní způsoby dia-gnostiky a molekulárně cílené léčby
Radiotherapy with rituximab may be better than radiotherapy alone in first line treatment of early-stage follicular lymphoma. Is it time to change the standard strategy?
The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide
A New Prognostic Score for Elderly Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: The Prognostic Role of Blood Monocyte and Lymphocyte Counts Is Absent
Microvessel density of mantle cell lymphoma. A retrospective study of its prognostic role and the correlation with the Ki-67 and the mantle cell lymphoma international prognostic index in 177 cases
Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma
Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial
Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
Missing publications? Search for publications with a matching author name.